Molex partners with Israeli start-up to expand medical markets
17 September 2013
Molex has signed definitive agreements as a strategic partner and investor in Vasa Applied Technologies, based in Or Yehuda, Israel.
The start-up that has developed a patent-pending technology that allows accurate measurements of fluid flow rates; initial designs will be targeting medical applications.
Tim Ruff, senior vice president of business development and corporate strategy, Molex said: “Vasa has developed a unique product that addresses urgent clinical needs. We expect this technology to have many more applications beyond medical markets when combined with Molex’s engineering talents.”
Jacob Polger, Vasa’s co-founder and CEO said: “With Molex’s global sales force and engineering capabilities, we expect to significantly increase our technology reach in new geographies and markets.”
Contact Details and Archive...